Pfizer negotiating possible acquisition of Wyeth
NEW YORK Pfizer is currently in talks to potentially acquire Wyeth in a deal that could be valued at more than $600 billion, the Wall Street Journal reported Friday morning.
According to the report, Pfizer and Wyeth executives have been negotiating a possible deal for months, but a deal is not imminent. Pfizer CEO Jeff Kindler told The Financial Times earlier this month that Pfizer may acquire a large pharmaceutical company. Published reports had speculated that this could be Bristol-Myers Squibb or Gilead Sciences. Neither Pfizer nor Wyeth communication executives would confirm the speculated merger.
Part of the attraction for Pfizer, according to published reports, is Wyeth’s position in biotechnology. The company has had success with Prevnar, its pediatric pneumococcal vaccine, which brought in $2.1 billion in sales over the first nine months of 2008, a 12% increase, according to company reports. A newer version of the vaccine, Prevnar-13, is currently in development.
Wyeth also co-markets Enbrel, a biologic drug positioned against arthritis, with Amgen. The Wyeth Consumer Healthcare division, which fields a significant portfolio across analgesics and cough-cold with Advil, ChapStick and Robitussin, may also be appealing to Pfizer. Pfizer has been criticized of late for selling its own over-the-counter division to Johnson & Johnson, noting that J&J’s McNeil Consumer Healthcare division is one of the positives for that company in a recession economy and a challenging environment throughout the prescription-drug industry.
Hy-Vee adopts NuVal Nutritional Scoring System to help customers determine food’s nutritional content
NEW YORK Hy-Vee has introduced a scoring system to allow customers to determine the nutritional content of the food they buy.
The Midwestern supermarket chain announced Thursday that it had adopted the NuVal Nutritional Scoring System, making it the first chain to do so in the Midwest. Golub Corp., which operates the Price Chopper chain in the Northeast, also has introduced the system, licensed by Braintree, Mass.-based NuVal, a joint venture of Topco Associates and Griffin Hospital in Derby, Conn.
“You really shouldn’t need a Ph.D. in nutritional biochemistry to figure out which kids’ breakfast cereal is more nutritious,” said David Katz, chairman of Griffin Hospital’s Yale Prevention Research Center. “If people want to make good decisions about the foods they buy and eat, then we should give them nutritional information they can understand.”
Hy-Vee plans to introduce the system to its stores in seven states.
Carex introduces Thera-Med Sinus Headache Cold Pack
OAKLAND, Calif. Carex Health Brands earlier this week launched its new Thera-Med Sinus Headache Cold Pack featuring Dual Temp Technology, with a soft side for cold and a smooth side for extra cold.
Designed for use over the eyes and/or forehead and featuring an adjustable strap, the new pack offers highly-targeted relief for sinus pain and headaches.